首页> 外文期刊>Cancer biology & therapy >Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.
【24h】

Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.

机译:从原位小鼠模型中分离自人骨肉瘤细胞系的肿瘤起始细胞的鉴定和基因表达谱。

获取原文
获取原文并翻译 | 示例
           

摘要

In the cancer stem cell model a cell hierarchy has been suggested as an explanation for intratumoral heterogeneity and tumor formation is thought to be driven by this tumor cell subpopulation. The identification of cancer stem cells in osteosarcoma (OS) and the biological processes dysregulated in this cell subpopulation, also known as tumor-initiating cells (TICs), may provide new therapeutic targets. The goal of this study, therefore, was to identify and characterize the gene expression profiles of TICs isolated from human OS cell lines. We analyzed the self-renewal capacity of OS cell lines and primary OS tumors based upon their ability to form sphere-like structures (sarcospheres) under serum-starving conditions. TICs were identify from OS cell lines using the long-term label retention dye PKH26. OS TICs and the bulk of tumor cells were isolated and used to assess their ability to initiate tumors in NOD/SCID mice. Gene expression profiles of OS TICs were obtained from fresh orthotopic tumor samples. We observed that increased sarcosphere efficiency correlated with an enhanced tumorigenic potential in OS. PKH26Hi cells were shown to constitute OS TICs based upon their capacity to form more sarcospheres, as well as to generate both primary bone tumors and lung metastases efficiently in NOD/SCID mice. Genomic profiling of OS TICs revealed that both bone development and cell migration processes were dysregulated in this tumor cell subpopulation. PKH26 labeling represents a valuable tool to identify OS TICs and gene expression analysis of this tumor cell compartment may identify potential therapeutic targets.
机译:在癌症干细胞模型中,已经提出了一种细胞层次结构来解释肿瘤内异质性,并且认为肿瘤形成是由这种肿瘤细胞亚群驱动的。骨肉瘤(OS)中癌症干细胞的鉴定以及在该细胞亚群中失调的生物学过程(也称为肿瘤引发细胞(TIC))可能会提供新的治疗靶标。因此,本研究的目的是鉴定和表征从人OS细胞系分离的TIC的基因表达谱。我们基于血清饥饿条件下形成球形样结构(油球)的能力分析了OS细胞系和原发性OS肿瘤的自我更新能力。使用长期标记保留染料PKH26从OS细胞系中鉴定出TIC。分离出OS TICs和大部分肿瘤细胞,并评估它们在NOD / SCID小鼠中引发肿瘤的能力。 OS TICs的基因表达谱是从新鲜的原位肿瘤样品中获得的。我们观察到,增加的sarcosphere效率与OS中增强的致瘤潜力相关。 PKH26Hi细胞在NOD / SCID小鼠中可以形成更多的肌球,并有效地产生原发性骨肿瘤和肺转移,因此可构成OS TIC。 OS TICs的基因组分析显示,在该肿瘤细胞亚群中,骨骼发育和细胞迁移过程均失调。 PKH26标记是鉴定OS TIC的有价值的工具,对该肿瘤细胞区室的基因表达分析可以鉴定潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号